Condition
IgAN clinical trials and research
As of November 12, 2026, Find a Trial lists 4 IgAN clinical trials that are recruiting, at sites in 10 countries (most in United States (3), Australia (2), Italy (2)). By phase: Phase 2 (3), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 10Countries
Newest IgAN clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Safety and helpful dose test of STL303 in adults with IgA nephropathy | Phase 2 | Newcastle, New South Wales and 7 other locations | Recruiting | May 26, 2026 |
| Ravulizumab for children with IgA nephropathy or IgA vasculitis nephritis | Phase 3 | Palo Alto, California and 14 other locations | Recruiting | Jun 17, 2025 |
| ADX-038 treatment for adults with complement-mediated kidney disease. | Phase 2 | Doral, Florida and 37 other locations | Recruiting | May 25, 2025 |
| Atacicept for multiple autoimmune glomerular diseases | Phase 2 | Brisbane, California | Recruiting | May 21, 2025 |
All recruiting trials (4)
-
Safety and helpful dose test of STL303 in adults with IgA nephropathy
A small, multi-center study will test different doses of STL303 or placebo to see if it helps adults with primary IgA nephropathy.
-
Ravulizumab for children with IgA nephropathy or IgA vasculitis nephritis
This trial will test whether intravenous ravulizumab is safe and changes disease markers in children aged 2 to under 18 with biopsy‑proven IgA nephropathy or IgA vasculitis nephritis.
-
ADX-038 treatment for adults with complement-mediated kidney disease.
This trial will test whether ADX-038 is safe and helps adults with complement-mediated kidney diseases such as IgA nephropathy, C3G, and IC-MPGN.
-
Atacicept for multiple autoimmune glomerular diseases
This will test whether weekly injections of atacicept can lower protein in the urine and help preserve kidney function in people aged 10 and older with IgA nephropathy, primary membranous nephropathy, or nephrotic syndromes such as MCD and FSGS.
Related topics
Quick answers
How many IgAN clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 10 countries. The most sites are in United States (3 trials), Australia (2 trials), Italy (2 trials), South Korea (2 trials), Spain (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.